Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Agilent TechnologiesA -3.41%93 Forward PE Ratio is 19.88 as of Jul. 18, 2026. GuruFocus rates A with a GF Score™ of 93/100 and a GF Value™ of $145.87 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 87 Medical Diagnostics & Research companies, Agilent Technologies ranks better than 54.02% on this metric.
Agilent Technologies (NYSE:A) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Agilent Technologies Forward PE Ratio Related Terms
Agilent Technologies Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Agilent Technologies's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Agilent Technologies Forward PE Ratio Chart
Agilent Technologies Annual Data
Trend
2016-10
2017-10
2018-10
2019-10
2020-10
2021-10
2022-10
2023-10
2024-10
2025-10
Forward PE Ratio
19.88
27.03
21.32
22.17
28.09
34.01
25.00
17.95
23.05
24.62
Agilent Technologies Quarterly Data
2016-01
2016-04
2016-07
2016-10
2017-01
2017-04
2017-07
2017-10
2018-01
2018-04
2018-07
2018-10
2019-01
2019-04
2019-07
2019-10
2020-01
2020-04
2020-07
2020-10
2021-01
2021-04
2021-07
2021-10
2022-01
2022-04
2022-07
2022-10
2023-01
2023-04
2023-07
2023-10
2024-01
2024-04
2024-07
2024-10
2025-01
2025-04
2025-07
2025-10
2026-01
2026-04
Forward PE Ratio
17.39
18.90
22.12
19.88
22.73
25.84
25.00
27.03
28.99
24.81
22.68
21.32
24.15
25.19
20.45
22.17
24.21
22.22
27.10
28.09
32.26
34.84
33.11
34.01
28.33
24.63
24.81
25.00
27.17
23.75
20.58
17.95
23.92
25.06
23.87
23.05
27.19
19.09
19.84
24.62
22.56
19.34
A vs NTRA, WAT, IDXX: Forward PE Ratio Comparison
For the Diagnostics & Research subindustry, Agilent Technologies's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Agilent Technologies Forward PE Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Agilent Technologies's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Agilent Technologies's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Agilent Technologies (A) has a Forward PE Ratio of 19.88 as of Jul. 18, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Agilent Technologies and its competitors. According to the industry distribution chart, Agilent Technologies ranks #40 out of 87 companies in the Medical Diagnostics & Research industry, placing it in the top 46%.
Is Agilent Technologies' Forward PE Ratio too high?
Agilent Technologies' current Forward PE Ratio is 19.88. The Medical Diagnostics & Research industry median Forward PE Ratio is 22.01. Agilent Technologies' value of 19.88 is 9.7% below this industry median. Based on the distribution chart, Agilent Technologies ranks #40 out of 87 companies in the Medical Diagnostics & Research industry, which is above the industry midpoint. Overall, Agilent Technologies has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Agilent Technologies' Forward PE Ratio compare to NTRA and WAT?
According to the Medical Diagnostics & Research industry distribution chart, Agilent Technologies ranks #40 out of 87 companies for Forward PE Ratio. This puts Agilent Technologies in the upper half of its industry. The industry median Forward PE Ratio is 22.01. Agilent Technologies' value of 19.88 is 9.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Diagnostics & Research company?
The median Forward PE Ratio among Medical Diagnostics & Research companies is 22.01, based on 87 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Agilent Technologies's current Forward PE Ratio of 19.88 is 9.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Agilent Technologies and its competitors. For the Medical Diagnostics & Research industry, the median Forward PE Ratio is 22.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Agilent Technologies's current Forward PE Ratio is 19.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Agilent Technologies stock overvalued right now?
Based on GuruFocus' analysis, Agilent Technologies (A) is currently considered Modestly Undervalued. The stock's GF Value™ is $145.87, compared to a current price of $131.46 — trading 9.9% below its estimated fair value. The current Forward PE Ratio is 19.88 and 9.7% below the Medical Diagnostics & Research industry median of 22.01. Agilent Technologies' overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Agilent Technologies (A), the current Forward PE Ratio is 19.88 as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Agilent Technologies (A) Overvalued in 2026?
Based on GuruFocus' analysis, Agilent Technologies stock appears to be undervalued.
The current stock price of $131.46 is trading 9.9% below its estimated GF Value™ of $145.87.
GuruFocus considers Agilent Technologies to be Modestly Undervalued.
Key valuation signals for A:
Forward PE Ratio: 19.88
GF Value™: $145.87 vs. price of $131.46 (9.9% below fair value)
Industry Position: 9.7% below the Medical Diagnostics & Research median (#40 of 87)
No single metric tells the full story. See the A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.
93GF Score
Get the complete analysis for A
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
A has been successfully added to your 
